These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11123971)

  • 1. Dopamine transporter and catechol-O-methyltransferase activities are required for the toxicity of 1-(3',4'-dihydroxybenzyl)-1,2,3, 4-tetrahydroisoquinoline.
    Kawai H; Kotake Y; Ohta S
    Chem Res Toxicol; 2000 Dec; 13(12):1294-301. PubMed ID: 11123971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism.
    Kawai H; Makino Y; Hirobe M; Ohta S
    J Neurochem; 1998 Feb; 70(2):745-51. PubMed ID: 9453570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
    Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
    J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tetrahydroisoquinoline derivatives as possible Parkinson's disease-inducing substances].
    Kotake Y
    Yakugaku Zasshi; 2002 Nov; 122(11):975-82. PubMed ID: 12440154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats.
    Huotari M; Passlin M; Nordberg HL; Forsberg M; Kotisaari S; Tuomisto L; Shintani F; Tanaka KF; Reenilä I; Laitinen K; Männistö PT
    J Neurosci Methods; 2001 Aug; 109(1):47-52. PubMed ID: 11489299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons.
    Storch A; Blessing H; Bareiss M; Jankowski S; Ling ZD; Carvey P; Schwarz J
    Mol Pharmacol; 2000 Mar; 57(3):589-94. PubMed ID: 10692500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity.
    Blessing H; Bareiss M; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2003 Jan; 42(2):139-51. PubMed ID: 12421594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
    Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
    Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of catechol-O-methyltransferase by 6,7-dihydroxy-3,4-dihydroisoquinolines related to dopamine: demonstration using liquid chromatography and a novel substrate for O-methylation.
    Cheng BY; Origitano TC; Collins MA
    J Neurochem; 1987 Mar; 48(3):779-86. PubMed ID: 2433397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA.
    Asanuma M; Miyazaki I
    BMC Neurosci; 2016 Jul; 17(1):52. PubMed ID: 27456338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine synthesis precedes dopamine uptake in embryonic rat mesencephalic neurons.
    Fiszman ML; Zuddas A; Masana MI; Barker JL; di Porzio U
    J Neurochem; 1991 Feb; 56(2):392-9. PubMed ID: 1671084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity of an endogenous brain amine, 1-benzyl-1,2,3,4-tetrahydroisoquinoline, in organotypic slice co-culture of mesencephalon and striatum.
    Kotake Y; Ohta S; Kanazawa I; Sakurai M
    Neuroscience; 2003; 117(1):63-70. PubMed ID: 12605893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
    Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
    Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
    Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH; Mytilineou C
    Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.
    Lannuzel A; Michel PP; Höglinger GU; Champy P; Jousset A; Medja F; Lombès A; Darios F; Gleye C; Laurens A; Hocquemiller R; Hirsch EC; Ruberg M
    Neuroscience; 2003; 121(2):287-96. PubMed ID: 14521988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-methylation of (+)-(R)- and (-)-(S)-6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in the presence of pig brain catechol-O-methyltransferase.
    Hötzl BK; Thomas H
    Chirality; 1997; 9(4):367-72. PubMed ID: 9275315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.
    Meyer MR; Maurer HH
    Chem Res Toxicol; 2009 Jun; 22(6):1205-11. PubMed ID: 19462939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice.
    Huotari M; Santha M; Lucas LR; Karayiorgou M; Gogos JA; Männistö PT
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1309-16. PubMed ID: 12438556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate.
    Lu H; Meng X; Yang CS
    Drug Metab Dispos; 2003 May; 31(5):572-9. PubMed ID: 12695345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.